The effect of paraprotein on platelet aggregation.

Area of Science:

• Hematology
• Immunology
• Biochemistry

Background:

• Paraproteinemia can be associated with platelet aggregation disorders.
• Investigating the in vitro effects of paraprotein on platelet function is crucial.

Purpose of the Study:

• To examine the disturbance of platelet aggregation in healthy blood donors induced by isolated paraprotein.
• To assess the impact of paraprotein on platelet response to various agonists.

Main Methods:

• Paraprotein was isolated from patients with paraproteinemia using Rivanol.
• Platelet aggregation in healthy donors was measured with and without added paraprotein and human immunoglobulins.
• Standard platelet aggregation inducers including adenosine diphosphate (ADP), collagen (COL), ristocetin (RIS), and epinephrine (EPI) were used.

Main Results:

• Addition of paraprotein significantly decreased maximal platelet aggregation levels in response to ADP, COL, RIS, and EPI.
• Paraprotein significantly prolonged the latent time of platelet aggregation with COL, RIS, and EPI.
• Human immunoglobulins did not significantly alter platelet aggregation or latent time.

Conclusions:

• Isolated paraprotein from patients with paraproteinemia causes significant in vitro platelet aggregation disturbances in healthy donors.
• Human immunoglobulins do not influence platelet aggregation, suggesting a specific effect of paraprotein.